The probiotic <i>Bacillus subtilis</i> BS50 decreases gastrointestinal symptoms in healthy adults: a randomized, double-blind, placebo-controlled trial

Gut Microbes · 2022 · PMC9590435 · PMID 36269141

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a possible trendno p-value reported

Although not significant, the point estimate and confidence interval favored BS50 at week 6, indicating a possible trend of a greater decrease in the mean change score.

also in 1,410 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.